Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-01-24 @ 3:20 AM
Study NCT ID:
NCT05391750
Status:
RECRUITING
Last Update Posted:
2025-01-24
First Post:
2022-04-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
Sponsor:
Organization: